In human CML almost no p53 mutations is found, but in the blast-crisis phase (BC) and accelerated phase (AP) of CML more than 20% of patients display mutated p53 [15, 16]. The gene discussed is TP53; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.